Page 37 - Lab Diagnostics Automation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lab diagnostics automation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lab Diagnostics Automation Today - Breaking & Trending Today

Updapted BA.4/5 COVID vaccines boost protection but might not surpass original formula

In a recent study posted to the bioRxiv preprint server, researchers at Beth Israel Deaconess Medical Center assessed the immunogenicity associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.5 bivalent messenger ribonucleic acid (mRNA) vaccine boosters. ....

Beth Israel Deaconess Medical Center , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , Image Credit , Automation Industry Focus , Coronavirus Disease Covid 19 , Ibonucleic Acid , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome ,

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade. ....

Elena Bonazzoli , Akiko Iwasaki , Bryan Chow , Stefania Bellone , Alessandro Santin , Tai Michaels , Emily Henderson , Gilead Sciences , National Institutes Of Health , Yale Cancer Center , Lab Diagnostics Automation , Cancer Foundation , Merck Co , Lab Diagnostics Automation Industry , Study Co , Eric Song , Automation Industry Focus , National Institutes , Endometrial Cancer , Uterine Cancer ,

Low-density granulocytes are phenotypically altered in people with long-COVID

In a recent study posted to the bioRxiv preprint server, researchers characterized low-density granulocyte (LDG) neutrophil (NP) proportion among individuals up to 14 months post-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection. ....

Kateryna Kon , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , Automation Industry Focus , Coronavirus Disease Covid 19 , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome ,

SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-Cov-2

SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the Phase 1 clinical study, recently labeled as a "national priority" by CAPNET (National Steering Committee for Therapeutic Trials and other Research on Covid-19). ....

United States , Philippe Pouletty , Hugo Mouquet , Institut Pasteur , Emily Henderson , Hugo Mouquet Inserm Joint Research Unit , Xencor Inc , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , National Steering Committee For Therapeutic Trials , Research On Covid , Institut Pasteur Human Immunology Laboratory , Truffle Capital , Human Immunology Laboratory , Inserm Joint Research Unit , National Steering Committee , Therapeutic Trials , Automation Industry Focus , Humoral Immunology , Scientific Director , Monoclonal Antibody , Ars Cov 2 , Covid 19 , Pre Exposure Prophylaxis ,